Alliance Pharma sees sales drop 7% amid COVID-19

24 July 2020 - Deborah Wilkes

Premium

Alliance Pharma reported sales down by 7% in the first half of 2020 as its prescription medicines business was affected by the COVID-19 pandemic. The UK-based company said sales of its consumer healthcare products “continued to be robust”.

Click tags below for more information on topics:

Alliance Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: